title: An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.
abstract: This is the second of two updates on Kawasaki disease. The first review focused on epidemiology and aetio-pathogenesis. Here, we review the clinical features and diagnosis of Kawasaki disease, as well as recent evidence on treatment, follow-up and cardiovascular outcomes.
authors: Department of Cardiology, The University of Melbourne, Melbourne, Victoria, Australia.
authors: Deane
authors: D
authors: Yim
authors: Nigel
authors: N
authors: Curtis
authors: Michael
authors: M
authors: Cheung
authors: David
authors: D
authors: Burgner
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D006328:Cardiac Catheterization; D004452:Echocardiography; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000601:surgery; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D015415:Biomarkers; D016756:Immunoglobulins, Intravenous; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha; D001241:Aspirin
keywords: Kawasaki disease; diagnosis; outcome; treatment